Filing Details

Accession Number:
0001209191-10-035084
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-06-21 13:00:00
Reporting Period:
2010-06-17
Filing Date:
2010-06-21
Accepted Time:
2010-06-21 13:56:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949858 Oncogenex Pharmaceuticals Inc. OGXI In Vitro & In Vivo Diagnostic Substances (2835) 954343413
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238250 A Michael Martino 1522 217Th Pl Se, Suite 100
Bothell WA 98021
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-06-17 1,073 $6.66 12,073 No 4 M Direct
Common Stock Acquisiton 2010-06-17 3,760 $7.25 15,833 No 4 M Direct
Common Stock Disposition 2010-06-17 4,833 $0.00 11,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock stock option (right to buy) Disposition 2010-06-17 1,073 $0.00 1,073 $6.66
Common Stock Stock option (right to buy) Disposition 2010-06-17 3,760 $0.00 3,760 $7.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-03-18 2018-03-18 No 4 M Direct
4,500 2009-05-12 2016-05-12 No 4 M Direct
Footnotes
  1. This is the weighted average price. The prices ranged from $14.00 to $14.25. The reporting person undertakes to provide on request a detailed breakout of the pricing.